Prostaglandins used to induce labor are given in microgram-to-milligram doses, depending on the specific medication and how it’s administered. The two prostaglandins used in clinical practice are misoprostol (a synthetic prostaglandin E1) and dinoprostone (prostaglandin E2), and each has its own dosing protocol. These aren’t medications you’d take on your own; they’re administered in a hospital setting under continuous monitoring, but understanding the doses and how the process works can help you know what to expect.
Misoprostol Doses: Oral vs. Vaginal
Misoprostol is the more commonly discussed prostaglandin for labor induction, partly because it’s inexpensive and can be given multiple ways. The standard dose is 50 micrograms (mcg) when taken by mouth or 25 micrograms when placed vaginally. The vaginal dose is lower because the medication absorbs more directly into the surrounding tissue and tends to produce a stronger local effect.
Either dose can be repeated every four hours if contractions haven’t started or aren’t yet painful. Your care team will assess your progress before giving another dose. Most protocols cap the total number of doses to avoid overstimulating the uterus, though the exact limit varies by hospital. The goal is to use the smallest effective amount to get labor established.
Dinoprostone Doses: Insert vs. Gel
Dinoprostone comes in two forms. The vaginal insert (sold as Cervidil) contains 10 milligrams of the prostaglandin locked inside a small polymer pouch. Rather than delivering the full dose at once, it slowly releases about 0.3 milligrams per hour over up to 12 hours. One major advantage of this form is that the insert can be physically removed if contractions become too strong or the baby shows signs of stress.
Dinoprostone is also available as a gel (Prepidil), which is applied directly to the cervix in smaller doses, typically 0.5 milligrams at a time. The gel can be repeated but cannot be retrieved once placed, which is why the insert has become more popular in many hospitals.
How Prostaglandins Actually Work
Prostaglandins do two things during induction: soften the cervix and encourage uterine contractions. The cervix-softening process, called cervical ripening, is often the more important step. These medications trigger an inflammatory-like response in the cervix that breaks down collagen cross-links and other structural proteins, making the tissue softer and more flexible so it can dilate.
Interestingly, the two prostaglandins work somewhat differently on the uterus itself. Lab studies have shown that misoprostol (PGE1) directly promotes uterine contractions, while dinoprostone (PGE2) does not stimulate contractions as reliably in isolated muscle tissue. This means dinoprostone works more as a cervical ripening agent, with contractions often following as a secondary effect. Different prostaglandin receptors on the uterine muscle can trigger either contraction or relaxation, which explains why the two medications produce distinct responses even though they belong to the same drug family.
What the Timeline Looks Like
Prostaglandin induction is not a fast process. Because the first priority is ripening a cervix that isn’t yet ready, the medication phase alone can take 12 to 24 hours before active labor kicks in. With the dinoprostone insert, you may have it in place for the full 12 hours before your team reassesses. With misoprostol, you could receive several doses spaced four hours apart.
If prostaglandins alone don’t establish strong, regular contractions, the next step is usually oxytocin (Pitocin) given through an IV. There’s an important safety window here: oxytocin cannot be started until at least six hours after the last prostaglandin dose. Using both at the same time significantly raises the risk of overstimulating the uterus. So if your cervix ripens well but contractions stall, expect a waiting period before the IV drip begins.
Risks to Be Aware Of
The primary concern with prostaglandin induction is uterine tachysystole, which means the uterus contracts too frequently (more than five times in a 10-minute window). This happens in roughly 1 in 10 induced labors. While a large meta-analysis found that tachysystole on its own wasn’t associated with poor outcomes overall, it does raise the likelihood of concerning changes in the baby’s heart rate. In the tachysystole group, nonreassuring heart rate patterns occurred in about 6.5% of cases compared to 3.4% without it. Abnormal decelerations in heart rate were also more common, at 93% versus 84%.
This is exactly why prostaglandin inductions happen in the hospital with continuous fetal monitoring. If the uterus is contracting too aggressively, the team can remove a dinoprostone insert, stop further misoprostol doses, or give medications to relax the uterine muscle.
Who Should Not Receive Prostaglandins
Prostaglandin induction is not safe for everyone. The clearest contraindication is a prior classical (vertical) cesarean incision or any surgery that cut into the uterine cavity, such as certain types of fibroid removal. The softening and contracting effects of prostaglandins on a scarred uterus increase the risk of uterine rupture.
Other contraindications include placenta previa (where the placenta covers the cervix), vasa previa (fetal blood vessels crossing the cervical opening), an active genital herpes outbreak, umbilical cord prolapse, or a baby lying sideways in the uterus. These are all situations where vaginal delivery itself carries serious risk, so any medication designed to bring on labor would be inappropriate.
For people with one prior low-transverse cesarean scar who are attempting a vaginal birth, the picture is more nuanced. Some providers will use dinoprostone gel cautiously in this group. One study of prostaglandin gel induction in people with a single prior cesarean found a 64% success rate for vaginal delivery, but this approach remains controversial and many hospitals avoid prostaglandins entirely in this population due to the rupture risk.